India, Feb. 7 -- India's pharmaceutical industry is projected to target a size of $ 130 billion by 2030, more than double its current size of $ 58 billion in 2024. As the "Pharmacy of the World," India holds a unique position globally, and maintaining trust, reliability, efficacy, and safety in health care products is pivotal for sustaining this growth and enhancing its competitive advantage across the global health care ecosystem.

In January 2024, the government took a significant step by notifying Schedule M, ensuring that Indian drug manufacturing guidelines align with global standards, benefiting both patients and the industry. However, the compliance deadline for Good Manufacturing Practices (GMP) under Schedule M of the Drugs and C...